Fluticasone: Clinical Applications and Pharmacological Profile
Fluticasone is a manufactured glucocorticoid—a type of steroid hormone that mimics the effects of cortisol—primarily utilized to manage inflammation and nasal congestion. Due to its efficacy in reducing swelling and irritation in the respiratory tract and skin, it has become a cornerstone in the treatment of various inflammatory conditions.
The medication is available in several forms, including esters such as fluticasone propionate (marketed as Flovent) and fluticasone furoate. While the base form is effective for nasal congestion, these esters are more commonly used as inhaled corticosteroids or topical anti-inflammatories. Its global importance is highlighted by its inclusion on the World Health Organization's List of Essential Medicines.
In the United States, fluticasone is widely accessible, available both by prescription and over-the-counter (OTC). In 2023, it ranked as the 26th most commonly prescribed medication in the U.S., with over 21 million prescriptions issued.
[ไม่มีภาพประกอบ]Key Facts
- Primary Use: Treatment of nasal congestion and inflammation.
- Administration: Delivered via intranasal spray, inhalation, or topical application.
- Global Status: Recognized as an Essential Medicine by the WHO.
- US Market: Over 21 million prescriptions in 2023; available as OTC.
- Protein Binding: High protein binding rate of 91.0%.
Pharmacological and Chemical Properties
Fluticasone is characterized by a complex chemical structure, identified by the formula C22H27F3O4S and a molar mass of 444.51 g·mol. It is categorized under several ATC (Anatomical Therapeutic Chemical) codes, including D07AC17, R01AD08, R03BA05, and R01AD58, reflecting its use across different respiratory and dermatological applications.
Pharmacokinetics
Pharmacokinetics refers to how the body absorbs, distributes, metabolizes, and excretes a drug. For fluticasone administered intranasally, the bioavailability—the proportion of the drug that enters the circulation—is low at 0.51%. This low systemic absorption helps minimize whole-body steroid side effects while maintaining local efficacy.
The drug is metabolized primarily in the liver through CYP3A4-mediated metabolism, a process involving the cytochrome P450 enzyme system. It has an elimination half-life of approximately 10 hours and is ultimately excreted via the kidneys.
[ไม่มีภาพประกอบ]Technical Specifications Summary
| Attribute | Detail |
|---|---|
| CAS Number | 90566-53-3 |
| Molecular Formula | C22H27F3O4S |
| Molar Mass | 444.51 g·mol |
| Intranasal Bioavailability | 0.51% |
| Protein Binding | 91.0% |
| Elimination Half-life | 10 hours |
| Primary Excretion Route | Kidney |
Frequently Asked Questions
What is fluticasone used for?
Fluticasone is used to treat nasal congestion and serves as an anti-inflammatory agent when used as a topical treatment or an inhaled corticosteroid.
How is fluticasone administered?
It can be administered through intranasal sprays, inhalation, or applied topically to the skin.
Is fluticasone available without a prescription?
Yes, in Canada and the United States, it is available as an over-the-counter (OTC) medication.
How does the body process fluticasone?
It is metabolized in the liver via the CYP3A4 enzyme and is excreted from the body through the kidneys.
What is the difference between fluticasone and its esters?
While fluticasone is used for nasal congestion, its esters—fluticasone propionate and fluticasone furoate—are more commonly utilized as inhaled corticosteroids and topical anti-inflammatories.